tiprankstipranks
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market
CONCORDBIO
Concord Biotech Ltd.
RESEARCH TOOLSreports
Want to see IN:CONCORDBIO full AI Analyst Report?

Concord Biotech Ltd. (CONCORDBIO) Financial Statements

3 Followers

Concord Biotech Ltd. Financial Overview

Concord Biotech Ltd.'s market cap is currently ₹157.62B. The company's EPS TTM is ₹26.24; its P/E ratio is 57.38; and it has a dividend yield of 0.50%. Concord Biotech Ltd. is scheduled to report earnings on July 31, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 10.55B₹ 12.00B₹ 10.17B₹ 8.53B₹ 7.13B
Gross Profit₹ 4.42B₹ 7.68B₹ 6.67B₹ 6.61B₹ 5.41B
Operating Income₹ 2.93B₹ 6.02B₹ 5.21B₹ 5.18B₹ 4.16B
EBITDA₹ 4.19B₹ 5.13B₹ 4.39B₹ 3.53B₹ 2.78B
Net Income₹ 2.61B₹ 3.72B₹ 3.08B₹ 2.40B₹ 1.75B
Balance Sheet
Cash & Short-Term Investments₹ 4.16B₹ 3.18B₹ 2.86B₹ 1.81B₹ 1.62B
Total Assets₹ 22.35B₹ 20.34B₹ 17.01B₹ 15.14B₹ 13.13B
Total Debt₹ 23.16M₹ 29.69M₹ 97.38M₹ 315.47M₹ 624.93M
Net Debt₹ -112.63M₹ 17.86M₹ -54.05M₹ 280.48M₹ 618.26M
Total Liabilities₹ 2.20B₹ 2.22B₹ 1.74B₹ 2.24B₹ 2.10B
Stockholders' Equity₹ 20.17B₹ 18.13B₹ 15.27B₹ 12.90B₹ 11.03B
Cash Flow
Free Cash Flow₹ 1.74B₹ 1.36B₹ 1.80B₹ 1.01B₹ 519.70M
Operating Cash Flow₹ 2.69B₹ 2.47B₹ 2.65B₹ 2.46B₹ 2.07B
Investing Cash Flow₹ -1.45B₹ -1.63B₹ -1.55B₹ -1.58B₹ -1.12B
Financing Cash Flow₹ -1.13B₹ -986.67M₹ -992.15M₹ -852.19M₹ -1.00B
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

Income Statement >

Concord Biotech Ltd. Debt to Assets

Balance Sheet >

Concord Biotech Ltd. Cash Flow

Cash Flow >

Concord Biotech Ltd. Forecast EPS vs Actual EPS

Earnings >